Roka Bioscience (ROKA) Reports Q2 Loss of $0.43
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Roka Bioscience Reports Second Quarter 2016 Financial Results
August 5, 2016 8:00 AM EDTWARREN, N.J., Aug. 5, 2016 /PRNewswire/ --Â Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the quarter and six months ended June 30, 2016.
Second Quarter 2016 Financial Results:Revenue for the quarter ended June 30, 2016 was $1.8 million compared with $1.5 million for the second quarter of 2015, and $1.6 million for the first quarter of 2016. The increase in second quarter revenue year-over-year resulted from an increase in the... More
